StockData
MRAIOTCServices-Misc Health & Allied Services, NECFiscal year ends December 31

Marpai, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$3.18+0.05 (+1.60%)

Close on Oct 19, 2026

Market cap
$82.24M
P/E (TTM)
–
Dividend yield
–

About Marpai

Services-Misc Health & Allied Services, NEC, SIC 8090

Marpai, Inc. is a healthcare technology platform company operating subsidiaries that provide third-party administrator and pharmacy benefit management services. The business serves self-insured employers who directly fund employee healthcare programs, with a client base primarily comprising small and medium-sized enterprises as well as local government entities. Its activities span three main revenue streams: health plan administration, in-house ancillary offerings, and third-party vendor services. These solutions include custom benefit plan design, claims adjudication, clinical care navigation, out-of-network claims repricing, specialty drug savings, and comprehensive pharmacy benefit management.

The company focuses its operations on the self-funded healthcare sector across the United States and maintains an Israeli operating subsidiary known as EYME Technologies, Ltd. As of December 31, 2025, Marpai engaged a workforce of 107 full-time employees. The company maintains its principal executive offices and headquarters in Tampa, Florida.

Summary of the business section of Marpai's latest annual report, written by StockData.

Company profile

Company

Legal name
Marpai, Inc.
Headquarters
Tampa, FL
Address
615 Channelside Drive, Suite 207 33602
Phone
(646) 303-3483
Employees
107, Dec 31, 2025
Industry
Services-Misc Health & Allied Services, NEC
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
UHY LLP, Melville, New York

Stock & identifiers

Ticker
MRAI
Exchange
OTC
IPO date
Oct 28, 2021
Shares outstanding
27M, Aug 13, 2026
Public float
$9.75M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Stock splits
1-for-4 reverse, Jun 29, 2023; 1-for-4 reverse, Jun 29, 2023
SEC CIK
1844392
CUSIP
571354109
ISIN
US5713541093
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Damien LamendolaChief Executive Officer, Director2,581,674
Steve Andrew JohnsonChief Financial Officer1,024,192
Dallas ScripChief Operating Officer400,000
John Paul PowersPresident410,000
Colleen DiClaudioDirector267,500
Sagiv ShivDirector613,667
Robert M. PonsDirector484,200
Jennifer Rosario CalabreseDirector225,000
Yaron EitanDirector1,224,073

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2024$362.00K$712.00K$514.00K$25–
FY2023$292.00K$288.00K$2.29M$53–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“we had a total of 107 full-time employees.”

Corporate history

Events identified from SEC filings